NYU Langone Health
301 East 17th Street
Suite 1410
New York
New York
10003
United States
Tel: 212-598-6761
60 articles with NYU Langone Health
-
Almost 90 Percent of People with Opioid Use Disorder Not Receiving Life-Saving Medication, New Study Finds
8/4/2022
While the opioid overdose and death epidemic continues to worsen across the United States, medications such as methadone, buprenorphine and extended-release naltrexone are proven to reduce opioid overdoses by more than 50 percent.
-
Physicians at New York University have successfully implanted pig hearts into the bodies of patients that were living but no longer showed neural function, a process called xenotransplantation.
-
Successful Heart Xenotransplant Experiments at NYU Langone Set Protocol for Pig-to-Human Organ Transplantation
7/12/2022
A team at NYU Langone Health successfully transplanted two genetically engineered pig hearts into recently deceased humans in June and July, marking the latest advances toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease.
-
Environmental Factors Predict Risk of Death
6/24/2022
Along with high blood pressure, diabetes, and smoking, environmental factors such as air pollution are highly predictive of people's chances of dying, especially from heart attack and stroke, a new study shows.
-
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
6/16/2022
A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke rehabilitation, a new study shows.
-
Mirati Therapeutics presented the first clinical data demonstrating CNS-specific activity of a KRASG12C inhibitor in patients with NSCLC with active and untreated CNS metastases.
-
Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers
5/26/2022
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug may be effective in treating several types of late-stage cancers in some patients.
-
Pancreatic transplants are difficult to pull off for Type 1 diabetes, but new technology may make it possible, and infusions of spinal fluid from young mice to older ones reportedly reverses memory loss.
-
For Three Years in a Row, Faculty Members at NYU Langone Health Elected to the National Academy of Sciences
5/10/2022
Benjamin G. Neel, MD, PhD, director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health and an internationally renowned expert in cell signaling and cancer biology, has been elected to the National Academy of Sciences.
-
David Sabatini has withdrawn his name for consideration for a faculty post at New York University Langone Health.
-
NYU Langone Health Launches New Hearing Loss and Screening Program for Low-Income Immigrant Families
4/5/2022
In the United States, five out of every 1,000 children suffer from hearing loss. After accounting for immigrant children from Mexico and China, that figure increases by at least 7.5 percent.
-
Pancreatic Cancer Cells Harness Normal Tissue Turnover to Build Protective Barriers
4/4/2022
In the presence of pancreatic tumors, certain immune cells break down structural proteins into molecules that trigger the building of dense tissue, a known barrier to therapy, a new study finds.
-
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
3/31/2022
By revealing the structure of a protein used by bacteria to pump out antibiotics, a research team designed an early-stage therapeutic that sabotages the pump and restores the effectiveness of antibiotics.
-
Skin Cancer Cells - As they Spread to the Brain - use an Alzheimer's Protein to Sabotage Immune Defenses
3/9/2022
Published online March 9 in Cancer Discovery, a journal of the American Association for Cancer Research, the study found that in melanoma, the deadliest form of skin cancer, cancer cells that have spread to the brain depend on amyloid beta to survive there.
-
9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder
3/2/2022
9 Meters Biopharma, Inc. announced today a collaboration with NYU Langone Health investigating the pre-clinical use of 9 Meters' gut-restricted tight junction regulator, NM-102, for an undisclosed autoimmune condition with a large unmet need.
-
Pioneer in Children's Behavioral and Mental Health Named Chair of the Department of Child & Adolescent Psychiatry at NYU Langone Health
2/21/2022
Jennifer Havens has been named the Arnold Simon Professor of Child and Adolescent Psychiatry and chair of the Department of Child and Adolescent Psychiatry at NYU Langone Health.
-
Cell Groups Push, Rather than Pull, Themselves Into Place As Organs Form and Cancers Spread
2/14/2022
Cells push and pull on surrounding tissue to move in groups as they form organs in an embryo, track down invading bacteria, and as they become cancerous and spread.
-
Study Confirms Site of Brain Region Responsible for Making Sure People Say Words as Intended
2/3/2022
A region crossing the folded surface of the top of the brain, called the dorsal precentral gyrus, plays an essential role in how people use the sound of their voices to control how they want the words to sound, a new study shows.
-
Mechanism Revealed Behind Loss of Smell with COVID-19
2/2/2022
Published online February 2 in the journal Cell, the new study found that infection with the pandemic virus, SARS-CoV-2, indirectly dials down the action of olfactory receptors, proteins on the surfaces of nerve cells in the nose that detect the molecules associated with odors.
-
Genetic and Lifestyle Calculator Reveals Which Younger Adults Are Most at Risk of Colorectal Cancer
1/27/2022
A new risk score can identify men and women under age 50 most likely to develop a cancer of the colon or rectum, an international study shows.